Enhancing Impact: The Use of VA-ECMO in a Critically Ill Pediatric Patient with Sickle Cell Disease, Acute Chest Syndrome, and Streptococcal Toxic Shock Syndrome

Streptococcal toxic shock syndrome (STSS) and acute chest syndrome (ACS) present significant challenges in managing pediatric patients with sickle cell disease (SCD).A patient with SCD developed severe STSS and ACS, necessitating advanced interventions due to rapid clinical deterioration.Initial treatments included broad-spectrum antibiotics and supportive care.Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was used to address severe cardiac and respiratory failure.During VA-ECMO, the patient experienced complications such as acute kidney injury and thrombosis, managed with fluids, diuretics, and anticoagulation adjustments.The patient was successfully extubated and subsequently discharged to an inpatient rehabilitation facility, demonstrating significant recovery and improved management of her condition.This case highlights the critical role of VA-ECMO in addressing severe complications of STSS and ACS in SCD patients and emphasizes the need for further research to refine ECMO protocols and understand the effects of post-COVID-19 changes on Group A Streptococcus virulence.